Edition:
United Kingdom

Ra Pharmaceuticals Inc (RARX.OQ)

RARX.OQ on NASDAQ Stock Exchange Global Market

6.23USD
20 Apr 2018
Change (% chg)

-- (--)
Prev Close
$6.23
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
90,566
52-wk High
$27.77
52-wk Low
$4.93

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.669
Sep '17 0.00 -0.675
Jun '17 0.00 -0.561
Mar '17 0.00 -0.504
FY 2016 Dec '16 0.00 -0.730
Sep '16 0.00 -0.401
Jun '16
Mar '16 1.88 -0.250
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 3 0.00 0.00 0.00 --
Quarter Ending Sep-18 3 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.67 2.00 0.00 22.05
Year Ending Dec-19 3 0.67 2.00 0.00 34.67
Earnings (per share)
Quarter Ending Jun-18 3 -0.51 -0.49 -0.54 --
Quarter Ending Sep-18 3 -0.54 -0.50 -0.57 --
Year Ending Dec-18 4 -2.12 -1.99 -2.26 -2.26
Year Ending Dec-19 4 -2.21 -2.02 -2.40 -2.89
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.02 32.74
P/E High - Last 5 Yrs. -- 293.18 45.72
P/E Low - Last 5 Yrs. -- 91.59 24.22
Beta -- 0.90 0.88
Price to Sales (TTM) -- 110.89 5.71
Price to Book (MRQ) 3.39 13.58 5.37
Price to Tangible Book (MRQ) 3.41 14.04 6.95
Price to Cash Flow (TTM) -- 71.40 23.32
% Owned Institutions 80.08 12.75 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 399.08 9.21
Sales (TTM) vs TTM 1 Yr. Ago -100.00 78.82 5.69
Sales - 5 Yr. Growth Rate -- 32.16 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago -136.23 25.00 19.36
EPS (TTM) vs TTM 1 Yr. Ago -166.36 -- --
EPS - 5 Yr. Growth Rate -- 38.99 10.76
Capital Spending - 5 Yr. Growth Rate -- 40.29 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.19
Current Ratio (MRQ) 13.98 5.30 2.98
LT Debt to Equity (MRQ) 0.00 22.96 12.18
Total Debt to Equity (MRQ) 0.00 24.62 16.45
Interest Coverage (TTM) -1,204.79 -99.35 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.02 54.44
Gross Margin - 5 Yr. Avg. -- 51.13 52.20
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -574.75 10.96
Operating Margin (TTM) -- -718.53 4.73
Operating Margin - 5 Yr. Avg. -- -596.06 6.40
Pre-Tax Margin (TTM) -- -693.00 5.57
Pre-Tax Margin - 5 Yr. Avg. -- -599.42 6.81
Net Profit Margin (TTM) -- -694.22 1.87
Net Profit Margin - 5 Yr. Avg. -- -602.27 3.09
Effective Tax Rate (TTM) -- 22.62 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.21 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,626,821 846,830,978
Net Income/Employee (TTM) -935,326 2,971,371 99,616,195
Receivable Turnover (TTM) -- 20.16 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.00 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -55.47 -1.11 10.95
Return on Assets - 5 Yr. Avg. -- -0.57 12.31
Return on Investment (TTM) -60.75 1.58 14.38
Return on Investment - 5 Yr. Avg. -- 2.21 16.10
Return on Equity (TTM) -174.09 2.41 16.07
Return on Equity - 5 Yr. Avg. -- 3.09 17.39
  1 Year 3 Year 5 Year
Sales % 20.37 -- --
EPS (TTM) % -1,051.33 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Ra Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 69.42%
# of Holders: 102
Total Shares Held: 22,414,128
3 Mo. Net Change: 3,933,548
# New Positions: 2
# Closed Positions: 1
# Increased Positions: 11
# Reduced Positions: 4
# Net Buyers: 7
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.